Matt McNamara

Mr. Matt McNamara was appointed as Director of Avita Medical Ltd., effective 22 October 2012. Mr McNamara is currently the Chief Investment Officer and Fund Manager of Octa Phillip Bioscience Managers. Matt has over 23 years experience in the healthcare & medical sciences sector. After initially being a molecular biology research assistant, Matt spent 11 years in Sales & Marketing and General Management with Merck & Co. and Johnson & Johnson Medical Pty. Ltd. respectively. He has served as SVP Business Development for a University of Sydney spin out, eBioinformatics Inc., and was CEO of a Life Sciences VC fund, SciCapital Pty. Ltd.

Article Timeline

Positions - Previous

PositionCompanyYearCompany's current rank
Non-Executive DirectorAvita Medical2012 - 201690

Total Shareholder Return as at 30/04/18

1 year TSR5 year TSR
7thAdvance NanoTek1645%107%
359thRefresh Group16%18%
496thAdvanced Share Registry-5%47%
662ndAvita Medical-34%-6%
721 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Source: Morningstar


90th↑Avita Medical$8.0m
94th↓Refresh Group$6.2m
95th↓Advanced Share Registry$6.0m
97th↓Advance NanoTek$5.1m
238 listed industrial companies ranked by revenue.
Source: Morningstar

BNiQ Disclaimer